Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Cash from Operations (2021 - 2025)

Lyra Therapeutics has reported Cash from Operations over the past 5 years, most recently at 6066000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 6066000.0 for Q4 2025, up 46.56% from a year ago — trailing twelve months through Dec 2025 was 28859000.0 (up 58.78% YoY), and the annual figure for FY2025 was 28859000.0, up 58.78%.
  • Cash from Operations for Q4 2025 was 6066000.0 at Lyra Therapeutics, up from 7361000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for LYRA hit a ceiling of 3381000.0 in Q2 2021 and a floor of 22455000.0 in Q1 2024.
  • Median Cash from Operations over the past 5 years was 11324500.0 (2021), compared with a mean of 11568950.0.
  • Biggest five-year swings in Cash from Operations: crashed 350.52% in 2022 and later surged 67.02% in 2025.
  • Lyra Therapeutics' Cash from Operations stood at 11297000.0 in 2021, then fell by 7.67% to 12164000.0 in 2022, then crashed by 56.68% to 19058000.0 in 2023, then skyrocketed by 40.43% to 11352000.0 in 2024, then skyrocketed by 46.56% to 6066000.0 in 2025.
  • The last three reported values for Cash from Operations were 6066000.0 (Q4 2025), 7361000.0 (Q3 2025), and 6590000.0 (Q2 2025) per Business Quant data.